Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

TITAN PHARMACEUTICALS INC (TTNP)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   10-K10-K10-K10-K10-K10-K/A10-K/A10-K
Revenues:  
    License revenue       0.215.11.7
Total revenues   [+]0.61.54.82.66.60.215.11.7
            Revenue growth   [+]-63.5%-68.5%85.7%-60.6%2978.1%-98.6%801.6%-54.2%
Cost of goods sold  -10.90.20.50.00.50.00.00.0
Gross profit  11.41.34.42.66.10.215.11.7
            Gross margin  2051.0%87.0%90.2%100.0%91.9%100.0%100.0%100.0%
Selling, general and administrative   [+]6.05.05.85.46.95.14.63.8
Research and development  4.85.75.95.17.59.66.14.7
Other operating expenses  10.8       
EBITDA   [+]-10.0-9.1-7.1-7.6-7.9-14.14.7-6.4
            EBITDA margin  -1788.9%-598.5%-145.9%-293.0%-119.1%-6551.2%31.3%-383.1%
Depreciation and amortization  0.20.20.30.20.40.40.40.4
EBIT   [+]-10.2-9.4-7.4-7.9-8.3-14.54.3-6.8
            EBIT margin  -1824.1%-613.0%-151.9%-302.3%-124.9%-6745.1%28.8%-404.5%
Non-recurring items  0.1       
Interest expense, net   [+]-0.10.00.81.00.90.40.0 
Other income (expense), net   [+]0.00.60.71.4-0.20.60.8-4.5
Pre-tax income  -10.2-8.8-7.4-7.5-9.3-14.35.1-11.3
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -10.2-8.8-7.4-7.5-9.3-14.35.1-11.3
            Net margin  -1832.3%-575.1%-153.1%-287.5%-140.6%-6654.4%34.1%-675.0%
   
Basic EPS   [+]($0.76)($0.90)($1.96)($9.78)($1.64)($4.05)$1.49($0.56)
Diluted EPS   [+]($0.76)($0.90)($1.96)($9.78)($1.64)($4.04)$1.44($0.56)
   
Shares outstanding (basic)   [+]13.49.73.80.85.73.53.520.1
Shares outstanding (diluted)   [+]13.49.73.80.85.73.53.620.1
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy